A new blood test measures cell-free DNA to detect ALS early and distinguish it from other neurological disorders.

A heart transplant recipient safely carried a baby to term using noninvasive DNA monitoring—marking a new milestone in maternal and transplant care.

The move aims to regulate cell and gene therapies, and xenografts or animal-to-human transplants. Such therapies are ...

A new study may finally change how amyotrophic lateral sclerosis (ALS) is diagnosed. Scientists from UCLA Health and the ...

They observe how the mobile DNA LINE-1 copies its sequence in human cells, revealing the precise mechanism of the ORF2p gene.

A new computational tool developed by researchers has uncovered genetic evidence directly linking Alzheimer’s disease to the ...

The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray showed promising effects on cognition and biomarkers ...

IMNN-001 program is currently advancing its OVATION 3 pivotal Phase 3 trial per planLAWRENCEVILLE, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced results from the randomized, double-blind, phase 3 ...

The goal of gene therapy is to permanently cure hereditary diseases. One of the most promising technologies for this is the ...

Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic ...